Evelo Biosciences, Inc. (EVLO)
OTCMKTS · Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
Oct 15, 2025, 8:00 PM EDT
Evelo Biosciences Market Cap
Evelo Biosciences has a market cap or net worth of $3.80 thousand as of October 17, 2025. Its market cap has decreased by -99.93% in one year.
Market Cap
3.80K
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since May 9, 2018, Evelo Biosciences's market cap has decreased from 517.90M to 3.80K, a decrease of -100.00%. That is a compound annual growth rate of -79.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 14, 2025 | 3.80K | -59.99% |
| Dec 30, 2024 | 9.49K | -99.19% |
| Dec 29, 2023 | 1.17M | -99.34% |
| Dec 30, 2022 | 176.48M | -45.62% |
| Dec 31, 2021 | 324.50M | -41.89% |
| Dec 31, 2020 | 558.43M | 328.67% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| May 9, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Glass House Brands | 702.42M |
| Elite Pharmaceuticals | 643.74M |
| Veradigm | 500.94M |
| Nika Pharmaceuticals | 495.49M |
| Northwest Biotherapeutics | 347.69M |
| CytoDyn | 332.83M |
| Silence Therapeutics | 311.27M |
| American Oncology Network | 277.25M |